The Efficacy of Systemic Valacyclovir (Valtrex) on Periodontitis

Summary

The experiment outlined in this proposal is designed to test the hypothesis that herpesvirus suppression by the systemic anti-herpesvirus valacyclovir (Valtrex) can significantly help to arrest the progressive course of severe marginal periodontitis in adult patients. A prospective, randomized, placebo-controlled, double-blind, clinical trial is employed to test this hypothesis.

Timeline

Start

2023-05-25

Primary completion

2024-03-01

Completion

2024-03-01

Drugs

Indications